Related Experiment Video

Updated: Aug 12, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Staphylococcus aureus in lower respiratory infections: clinical relevance of antimicrobial resistance

P M Shah1

  • 1Klinikum der J.W. Goethe Universitaet, Zentrum der Inneren Medizin, Schwerpunkt Infektiologie, D-60590 Frankfurt am Main, Germany. shah@em.uni-frankfurt.de

Seminars in Respiratory Infections
|September 20, 2001
PubMed

Insights

Staphylococcus aureus infections are common, with rising resistance to oxacillin (methicillin) and other antibiotics. Reduced susceptibility to glycopeptides is also a growing concern in healthcare settings.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Antimicrobial Resistance

Background:

  • Staphylococcus aureus is a leading cause of hospital-acquired and community-acquired infections.
  • Increasing oxacillin (methicillin) resistance, reaching up to 60% in some regions, is a significant clinical challenge.
  • Co-resistance to multiple antibiotics is common among resistant Staphylococcus aureus strains.

Purpose of the Study:

  • To highlight the increasing prevalence of antibiotic resistance in Staphylococcus aureus.
  • To address the growing concern regarding reduced susceptibility to critical antibiotics like oxacillin (methicillin) and glycopeptides.

Main Methods:

  • Literature review and synthesis of existing data on Staphylococcus aureus antimicrobial resistance patterns.
  • Analysis of reported resistance rates in nosocomial and community-acquired infections.
  • Monitoring trends in resistance to oxacillin (methicillin) and glycopeptides.

Main Results:

  • Staphylococcus aureus is a primary cause of nosocomial infections globally.
  • Oxacillin (methicillin) resistance rates in Staphylococcus aureus are alarmingly high in certain geographical areas and intensive care units.
  • Emerging reports indicate reduced susceptibility to glycopeptides, posing a threat to treatment options.

Conclusions:

  • The rise in oxacillin (methicillin)-resistant Staphylococcus aureus necessitates urgent surveillance and infection control measures.
  • The emergence of glycopeptide-reduced susceptibility in Staphylococcus aureus strains requires further investigation and development of alternative therapies.
  • Effective strategies are needed to combat the escalating antimicrobial resistance crisis posed by Staphylococcus aureus.

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...